SLC46A3 and hepatocellular carcinoma: The expression of SLC46A3 (FKSG16) was downregulated in around 80% of human HCC tissues compared to non-tumor adjacent tissues, while tumors that expressed low levels of SLC46A3 had more aggressive phenotypes and shorter survival times after surgery [63].